Big Players moving in and out of NutriSystem

It looks like the big investors are taking up action on Nutrisystem this past month (a member of the ten grand portfolio).

Firms who like the value:

• Citigroup Financial Products, increases total stake to 5.9%
• Bridger Management, increases total stake to 5.3%
• Legg Mason Oppotrunity Trust, increases total stake 10.2%

Firms who had enough:
Turner Investment Partners, sold off more than 5% of its shares.

What's interesting is that Gregory R. Badishkanian, a Citi Investment Research analyst removed NTRI from their "top picks" citing possible first quarter softness. He still recommends a buy rating though. Why would you do that if your firm just bought 2.1 million shares of NTRI just a few days ago? What's the difference between a top pick, and a buy rating?

Who am I to call out Citigroup though? These folks manage gajillions of dollars. I'm just managing a measley 10k. I guess we'll just have to wait and see on Feb.19th when NurtiSystem reports.

You can read the full Forbes article detailing these moves. I did an analysis of NutriSystem just a few weeks ago and don't think the competing alternative drug (Alli) will have long lasting impacts.